SyntheMed to Present at the C.E. Unterberg, Towbin Life Sciences Conference (PR Newswire via Yahoo! Finance)
SyntheMed, Inc. , a biomaterials company engaged in the development and commercialization of anti-adhesion and drug delivery products, announced today that Robert P. Hickey, President and CEO, will present at the C.E.

U.S. Food and Drug Administration Issues Non-Approvable Letter for Faropenem (PR Newswire via Yahoo! Finance)
Replidyne, Inc. and Forest Laboratories, Inc. , reported today the U.S. Food and Drug Administration has issued a non- approvable letter for Replidyne's new drug application for faropenem medoxomil, a novel oral, community antibiotic.

Med Enclosure, LLC With Several IRB Approvals With "Non Significant Risk" Determination Withdraws Irrelevant IDE (Medical News Today)
CPC of America, Inc. (OTC Bulletin Board: CPCF.OB) reports that its subsidiary, Med Enclosure, LLC, has withdrawn the Investigational Device Exemption ("IDE") application submitted July 12, 2005 to the U. S. Food and Drug Administration ("FDA"), Center for Devices and Radiological Health under provisions of the Federal Food, Drug, and Cosmetic Act ("Act"), 21 U.S.C. 360j(g), and 21 C.F. [click